Real Estate
Health Expert of the Month
Quality Affordable Dental Coverage

EurekAlert! - Medicine and Health

05/30/2020 12:00 AM
The fight goes on: Clinical trial shows promising new treatment for rare blood cancer
(Nagoya University) Although lymphoma is one of the most common types of blood cancer, it has a rare subtype for which no effective treatment regimens are known. For the first time, Nagoya University researchers and colleagues in Japan have conducted clinical trials for a new treatment protocol and report it to be quite promising.

05/29/2020 12:00 AM
Largest study of its kind of women in labor finds nitrous oxide safe, side effects rare
(University of Colorado Anschutz Medical Campus) Researchers at the University of Colorado College of Nursing and the School of Medicine Department of Anesthesiology at the Anschutz Medical Campus found that the use of nitrous oxide (N2O) as a pain relief option for individuals in labor is safe for newborn children and laboring individual, and converting to a different form of pain relief such as an epidural or opioid is influenced by a woman's prior birth history and other factors.

05/29/2020 12:00 AM
RIT scientists develop method to help epidemiologists map spread of COVID-19
(Rochester Institute of Technology) Rochester Institute of Technology scientists have developed a method they believe will help epidemiologists more efficiently predict the spread of the COVID-19 pandemic. Their new study, published in Physica D: Nonlinear Phenomena, outlines a solution to the SIR epidemic model, which is commonly used to predict how many people are susceptible to, infected by, and recovered from viral epidemics.

05/29/2020 12:00 AM
Oesophageal surgery: Quality increases with larger case volumes
(Institute for Quality and Efficiency in Health Care) Oesophageal surgery: quality increases with larger case volumes. Greater survival probabilities in hospitals where complex oesophageal surgery is performed more frequently.

05/29/2020 12:00 AM
How the coronavirus could be prevented from invading a host cell
(University of California - Riverside) How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution. The scientists, led by Maurizio Pellecchia in the UC Riverside School of Medicine, report in the journal Molecules that two proteases -- enzymes that break down proteins -- located on the surface of host cells and responsible for processing viral entry could be inhibited.

05/29/2020 12:00 AM
Researchers from Syracuse University and SUNY ESF track COVID-19 in wastewater
(Syracuse University) A scaleable wastewater treatment program originating in Syracuse NY is helping a growing number of New York State counties track the spread of COVID-19.

05/29/2020 12:00 AM
Chimeron Bio & George Mason NCBID partner on COVID-19 vaccine using ChaESARTM technology
(George Mason University) RNA therapeutics company, Chimeron Bio and George Mason University's National Center for Biodefense and Infectious Diseases (NCBID) announced their partnership to develop a Coronavirus (COVID-19) vaccine based on Chimeron Bio's ChaESARTM self-amplifying RNA technology and will integrate Mason's complimenting expertise and Biomedical Research Laboratory (BRL), a National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) supported, state-of-the-art Regional Biocontainment Laboratory for the rapid screening of the company's vaccine pipeline.

05/29/2020 12:00 AM
Evolution of pandemic coronavirus outlines path from animals to humans
(Duke University Medical Center) A team of scientists studying the origin of SARS-CoV-2, the virus that has caused the COVID-19 pandemic, found that it was especially well-suited to jump from animals to humans by shapeshifting as it gained the ability to infect human cells.

05/29/2020 12:00 AM
Key grant positions USC as leader in dental and craniofacial tissue regeneration
(University of Southern California) The $30 million grant from the National Institute of Dental and Craniofacial Research funds a consortium of California academic institutions that includes USC.

05/29/2020 12:00 AM
A rising tide of marine disease? How parasites respond to a warming world
(University of Washington) A recent study from the University of Washington explores the ways parasitism will respond to climate change, providing researchers new insights into disease transmission. The paper was published May 18 in the journal Trends in Ecology and Evolution.

05/29/2020 12:00 AM
When COVID-19 meets flu season
(Northwestern University) As if the COVID-19 pandemic isn't scary enough, the flu season is not far away. How severe will the flu season be as it converges with the COVID-19 outbreak? What can we do to prepare? Dr. Benjamin Singer, a Northwestern Medicine pulmonologist who treats COVID-19 patients in the intensive care unit, outlines the best defense against influenza, which also may protect against coronavirus.

05/29/2020 12:00 AM
SARS-CoV-2 possibly emerged from shuffling and selection of viral genes across different species
(American Association for the Advancement of Science) A combination of genetic shuffling and evolutionary selection of near-identical genetic sequences among specific bat and pangolin coronaviruses may have led to the evolution of SARS-CoV-2.

05/29/2020 12:00 AM
University of Tennessee Health Science Center researcher receives NIH award for multimorbidity research
(University of Tennessee Health Science Center) A UTHSC researcher has been awarded an R15 grant from the National Institutes of Health for her work to identify and understand trends in age-related multimorbidity. Charisse Madlock-Brown, Ph.D., assistant professor in the Health Informatics and Information Management Program is the principal investigator on the study titled 'Data-Driven Identification of Costly Multi-Morbidity Groupings and Their Progression.'

05/29/2020 12:00 AM
Researchers develop new method to map cholesterol metabolism in brain
(Swansea University) A team of researchers led by Swansea University have developed new technology to monitor cholesterol in brain tissue which could uncover its relation to neurodegenerative disease and pave the way for the development of new treatments.

05/29/2020 12:00 AM
About 30 Million Euros for excellent research
(University of Freiburg) Collaborative Research Centre 1425 investigates ways for 'better scarring' of the heart under the leadership of the University Heart Centre Freiburg - Bad Krozingen / Continuation of two collaborative research centres about epigenetics and viral infections at the University of Freiburg - Medical Center.

05/29/2020 12:00 AM
Assessing cancer diagnosis in children with birth defects
(Baylor College of Medicine) In this study, led by Baylor College of Medicine and Texas Children's Hospital, researchers provide a better understanding of cancer risk in children with birth defects.

05/29/2020 12:00 AM
NASA's Commercial Crew Program Brings Extra Hands to Science on the Space Station
(NASA/Johnson Space Center) The International Space Station soon returns to a stable rotation of four US Operating Segment (USOS) crew members thanks to the first launch of NASA's Commercial Crew Program (CCP).

05/29/2020 12:00 AM
Study: Public health campaigns can do better on cannabis harm reduction
(University at Buffalo) Researchers surveyed nearly 500 attendees at the 2019 Hash Bash in Ann Arbor, Michigan, to learn about cannabis enthusiasts' awareness of cannabis harm reduction strategies. The results indicate a need for better public health campaigns.

05/29/2020 12:00 AM
Combined cediranib and olaparib presents similar activity to standard of care treatment
(NRG Oncology) Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy did not improve progression-free survival (PFS) outcomes for women with platinum-sensitive ovarian cancer;, however, activity between the treatments were similar in patients.

05/29/2020 12:00 AM
Using brain imaging to demonstrate weaker neural suppression for those with autism
(University of Minnesota Medical School) A University of Minnesota Medical School researcher recently published an article in Nature Communications that shows the differences in visual motion perception in autism spectrum disorder are accompanied by weaker neural suppression in the visual cortex of the brain.

05/29/2020 12:00 AM
Older men worry less than others about COVID-19
(Georgia State University) Older men may be at greater risk of contracting COVID-19 because they worry less about catching or dying from it, according to a new study by researchers at Georgia State University. This is a concern because older men are already more at risk of severe or fatal COVID-19 infections, and the study participants who were most worried about COVID-19 were also the most likely to have implemented protective behavior changes.

05/29/2020 12:00 AM
Trastuzumab combined with trimodality treatment does not improve outcomes for patients
(NRG Oncology) Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival (DFS) outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.

05/29/2020 12:00 AM
Paid sick leave mandates hold promise in containing COVID-19
(Georgia State University) Paid sick leave (PSL) mandates like those found in the federal government's Families First Coronavirus Response Act may be helping to slow the spread of COVID-19, according to a new study by health economists at Georgia State and Tulane universities.

05/29/2020 12:00 AM
New model predicts the peaks of the COVID-19 pandemic
(Santa Fe Institute) This week in the journal Frontiers, researchers describe a single function that accurately describes all existing available data on active COVID-19 cases and deaths -- and predicts forthcoming peaks.

05/29/2020 12:00 AM
Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS
(NRG Oncology) The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43. The trial did find a statistically non-significant, modest (19%) reduction in the rate of recurrence among women that received trastuzumab, but this difference was not statistically significant.

powered by EurekAlert! - Medicine and Health
The premier online source for science news since 1996. A service of the American Association for the Advancement of Science.



Medical Doctor

Copyright © Russian Market 2003. All rights reserved. Disclaimer